Pharmaceuticals, Biotechnology and Life Sciences
NEW YORK–(BUSINESS WIRE)–TransPerfect Life Sciences, a leading provider of technologies and services to support clinical trials and product development for…
Life Sciences Industry Leader Andrew Setikas to Take the Helm of CLSA’s Business Development, Membership and Strategic Alliance Activities SAN…
Proceeds Will Fund Start-Up Activities for Current and Future Clinical Trials HIGH POINT, N.C.–(BUSINESS WIRE)–vTv Therapeutics Inc. (Nasdaq:VTVT) (the “Company”)…
LEXINGTON, Mass.–(BUSINESS WIRE)–Fractyl Laboratories Inc. (Fractyl) today announced the hiring of Margaret Borys as Chief Commercial Officer (CCO) and Juan…
Neratinib becomes the first anti-HER2 treatment to be approved in Australia, as extended adjuvant therapy for early stage HER2-positive breast…
— If Approved, AR101 Will Be the First Medicine for This Life-Threatening Condition — BRISBANE, Calif.–(BUSINESS WIRE)–Aimmune Therapeutics, Inc. (Nasdaq:…
FLEXBUMIN 25% [Albumin (Human)], USP, 25% Solution is indicated for hypovolemia, hypoalbuminemia, (burns, Adult Respiratory Distress Syndrome (ARDS), and nephrosis),…
ATHENS, Ga–(BUSINESS WIRE)–ArunA Bio, a leader in the development of exosomes and exosome therapeutics for the treatment of neurodegenerative disorders,…
OSAKA, Japan & MOUNTAIN VIEW, Calif.–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/ai?src=hash" target="_blank"gt;#ailt;/agt;–Ono Pharmaceutical Co., Ltd., a Japanese pharmaceutical research and development company, and…
CAMBRIDGE, England & BOSTON–(BUSINESS WIRE)–Bicycle Therapeutics, a biotechnology company pioneering a new class of therapeutics based on its proprietary bicyclic…